학술논문

Reversion From Chronic to Episodic Migraine and Effects on Patient-reported Outcomes Following Treatment With Erenumab: Post-hoc Analysis of the Randomised, 12-week, Double-blind DRAGON Study
Document Type
Journal
Source
CEPHALALGIA; SEP 2022, 42 1_SUPPL, p29-p31, 3p. Supplement: 1_
Subject
Language
English
ISSN
14682982